Back in May 2026, OMB issued a proposed rule that would lay out the authority and framework for political appointees to have a much stronger hand in grant approval decisions. See article by AP here. AP also linked back to a Executive Order on the topic back in August 2025 - here. It might reduce the chance the political grant cuts would get contested in court as happened when grants were abruptly defunded around March-April 2025 (here).
- See 108pp OMB proposal here; comment ran to July 13.
- The OMB policy stated in part:
- Although Federal spending through grants and other types of Federal financial assistance has grown exponentially since the initial establishment of OMB's policies in earlier Circulars and 2 CFR, corresponding policies capable of ensuring transparency, accountability, and oversight for this increased level of spending remain deficient in the current regulatory text. As a result, Federal programs, and the activities performed under Federal awards, have not always remained properly aligned with core purposes authorized by law, nor served the needs of the American public as intended.
- This lack of transparency, accountability, and proper oversight became increasingly clear between 2021 and 2024. Federal awards were often used during those years to promote a “woke” policy agenda that did not reflect the values of the vast majority of the American public...
Here comes what may be a related document in the set, from NIH, about presentation of data from NIH grant reviews - here. Dated August 14, 2026. It's titled, Request for Information (RFI) on Proposed Changes to Reporting Outcomes from NIH Peer Review, Notice Number: NOT-OD-26-088. Issued 8/14, your comments due 10/13.
##
I'll let Chat GPT discuss the details.
See also a ten-page AI generated white paper on this topic >>> here <<< .
##
NIH has issued something notable. And it fits almost hand-in-glove with the OMB proposal from May 2026, although the NIH notice here is itself framed as a technical reform intended to reduce false precision in peer-review scoring.
The chronology makes the architecture clearer. In November 2025, NIH adopted its Unified Funding Strategy, effective with the January 2026 Council round, expressly moving away from rigid paylines and toward decisions that balance peer review with health priorities, scientific opportunities, workforce considerations, portfolio balance, and available funds. (Grants.gov)
Then on May 29, 2026, OMB proposed its government-wide rule requiring senior appointees to independently review discretionary awards rather than routinely defer to peer-review recommendations. (Federal Register); 108pp. Comments closed.
Now: on August 14, NIH proposes to remove the principal quantitative output of peer review from everybody downstream of the study section. (Grants.gov)
That last point is more substantial than the headline suggests.
- Today, an R01 might emerge from study section with, say, an impact score of 18 and 2nd percentile. The PI sees it. Program sees it. Institute leadership sees it. Council sees it. Everybody knows that this was an exceptionally highly ranked application.
- Under the proposal, the reviewers would still score it numerically, and NIH would still calculate the final impact score behind the curtain—but the PI, institution, program staff, ICO leadership and Advisory Council would not receive either that score or the percentile. They would be told merely:
| Current | Proposed |
|---|---|
| Impact score 18, 2nd percentile | Most competitive |
| Impact score 27, 23rd percentile | Most competitive |
| Impact score 31, 28th percentile | Competitive |
| Below discussion threshold | Not discussed |
The first two applications therefore become formally indistinguishable in the information delivered to the people making the funding decision—even though the study section may have regarded one as markedly stronger.
NIH says this is intentional: exact scores have “imperfect discriminative ability,” and removing them will cause program officials to pay greater attention to critiques and exercise judgment about NIH priorities and portfolio considerations. (Grants.gov)
There are really two stories here
One is a perfectly respectable science-of-peer-review argument. A score of 18 versus 21 isn't a laboratory measurement. Reviewer composition, study-section dynamics and random variation matter; the literature has long questioned whether tiny score differences justify cliff-edge funding decisions. NIH's argument is basically: stop pretending a noisy ordinal judgment is a micrometer. That's defensible, and NIH specifically says that critiques, criterion scores, discussion summaries, and the actual peer-review process remain. (Grants.gov)
But the second story is governance.
NIH isn't merely saying, “Don't fetishize the score.” It proposes to withhold the score altogether from program officials, Institute directors, Advisory Councils, applicants and institutions. That substantially reduces the externally visible constraint imposed by peer review. The old system made departures from review rank conspicuous: Why was a 3rd-percentile application passed over while an 18th-percentile application was funded? Under the proposed system, both may simply read MOST COMPETITIVE.
And that intersects remarkably with the Unified Funding Strategy. NIH already says ICOs should no longer use paylines and should instead integrate scientific merit with institutional priorities, health priorities, workforce, portfolio and financial considerations. (Grants.gov) The new proposal removes much of the numerical information that could constrain—or at least make visible—how far those discretionary decisions depart from study-section ranking.
Then put the OMB May 29 proposal next to it. OMB's proposed government-wide regulation says senior appointees should exercise independent judgment rather than routinely defer to recommendations and explicitly makes peer-review recommendations advisory. (Federal Register)
So I would distinguish intent from institutional effect. The NIH RFI does not say, “We want political appointees overriding scientists,” and it would be overstating the document to describe it that way. But institutionally, the sequence is striking:
- November 2025: abolish dependence on paylines →
- May 2026 OMB: emphasize independent judgment of political leadership over discretionary grants →
- August 2026 NIH: collapse peer-review results into three broad categories and conceal exact scores from downstream decision-makers.
That combination transfers information and discretion away from an easily auditable numerical peer-review ranking and toward programmatic/leadership judgment.
One additional detail caught my eye [writes Chat GPT]: NIH released NOT-OD-26-088 on Friday, August 14—the same day NIH held its previously scheduled public webinar, “Understanding NIH's Unified Funding Strategy: What the Research Community Needs to Know.” (Grants.gov) So this appears less like an isolated CSR housekeeping proposal than another deliberate step in implementing the Unified Funding Strategy.
And there's a terrific blog headline hiding in the mechanics:
NIH Peer Review: The Score Will Still Exist. You Just Won't Be Allowed to See It.
The RFI comment deadline is October 13, 2026. (Grants.gov)
I think this is considerably more interesting when framed as the third act of the 2025–26 story—Unified Funding Strategy → OMB grant rule → NIH score suppression—rather than as a standalone item that “NIH changes peer review details.”
